FDA Approves 1st OTC Drug for Women With Overactive Bladder

Share this article:
FDA Approves 1st OTC Drug for Women With Overactive Bladder
FDA Approves 1st OTC Drug for Women With Overactive Bladder

The drug Oxytrol has been approved by the U.S. Food and Drug Administration as the first over-the-counter treatment for women 18 and older with overactive bladder.

Oxytrol contains oxybutynin, among a class of drugs called anticholinergics that are designed to relax the bladder muscle. Oxytrol is a patch applied to the skin every four days, the FDA said in a news release.

The drug will remain available for adult men by prescription only, the agency said.

Side effects reported during clinical testing included skin irritation at the patch site, dry mouth, and constipation.

Oxytrol for Women is marketed by Merck, based in Whitehouse Station, N.J.

Share this article:
You must be a registered member of RUN to post a comment.
close

Next Article in Overactive Bladder (OAB)

More in Overactive Bladder (OAB)

Repeat BTXA Injections Okay for Non-Neurogenic OAB

Repeat injections of onabotulinumtoxinA (BTXA) appear to benefit patients with non-neurogenic overactive bladder.